Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07210554 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study of Stapokibart Injection in Subjects With Moderate to Severe Bullous Pemphigoid

StatusNot Yet Recruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
This study is a multicenter, randomized, double-blind, placebo-controlled phase III clinical study to evaluate the efficacy, safety, pharmacokinetics, pharmacodynamics, and immunogenicity of Stapokibart in subjects with Moderate to Severe Bullous Pemphigoid.
Trial Details
NCT Number NCT07210554
Lead Sponsor Chengdu Kangnuoxing Biopharma,Inc.
Conditions
(from sponsor)		 Bullous Pemphigoid (BP)
Related terms Pemphigoid, Bullous
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov